We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$5.74B
AUM Growth
+$541M
(+10%)
Cap. Flow
+$368M
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
14.68%
Holding
2,530
New
949
Increased
622
Reduced
470
Closed
486
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$203M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$91.1M |
| 3 |
PG&E
PCG
|
+$57.7M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$53.7M |
| 5 |
Boston Scientific
BSX
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Japan ETF
EWJ
|
+$67M |
| 2 |
iShares MSCI India ETF
INDA
|
+$55.1M |
| 3 |
Apple
AAPL
|
+$50.9M |
| 4 |
Intuit
INTU
|
+$43.3M |
| 5 |
Lowe's Companies
LOW
|
+$41.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.3% |
| 2 | Technology | 11.38% |
| 3 | Healthcare | 10.73% |
| 4 | Industrials | 10.27% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Frontline
FRO
$8.75B
| $133K | ﹤0.01% |
+29,056
| New | +$162K |
|
|
NSL
1902
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $133K | ﹤0.01% |
+20,500
| New | +$135K |
|
|
AFSI
1903
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $133K | ﹤0.01% |
13,256
-15,590
| -54% | -$177K |
|
1904
Rockwell Medical
RMTI
$26.2M
| $132K | ﹤0.01% |
+206
| New | +$145K |
|
|
EMWP
1905
DELISTED
Eros Media World PLC
EMWP
| $132K | ﹤0.01% |
+685
| New | +$169K |
|
|
AGEN
1906
Agenus
AGEN
$249M
| $131K | ﹤0.01% |
2,048
+564
| +38% | +$43K |
|
|
PHD
1907
DELISTED
Pioneer Floating Rate Fund
PHD
| $131K | ﹤0.01% |
+11,390
| New | +$134K |
|
1908
Ardelyx
ARDX
$1.24B
| $130K | ﹤0.01% |
+19,729
| New | +$117K |
|
|
WIN
1909
DELISTED
Windstream Holdings Inc
WIN
| $129K | ﹤0.01% |
+13,957
| New | +$143K |
|
1910
LSB Industries
LXU
$881M
| $128K | ﹤0.01% |
19,032
-19,427
| -51% | -$122K |
|
|
LAYN
1911
DELISTED
Layne Christensen Co
LAYN
| $128K | ﹤0.01% |
+10,172
| New | +$130K |
|
1912
Codexis
CDXS
$135M
| $127K | ﹤0.01% |
+15,181
| New | +$105K |
|
|
ITI
1913
DELISTED
Iteris, Inc.
ITI
| $126K | ﹤0.01% |
+18,020
| New | +$122K |
|
1914
Valhi
VHI
$385M
| $125K | ﹤0.01% |
1,695
-1,168
| -41% | -$67K |
|
1915
Karyopharm Therapeutics
KPTI
$168M
| $124K | ﹤0.01% |
+860
| New | +$138K |
|
1916
Energy Recovery
ERII
$434M
| $123K | ﹤0.01% |
14,064
-2,773
| -16% | -$25.3K |
|
|
PMM
1917
Franklin Managed Municipal Income Trust
PMM
$275M
| $123K | ﹤0.01% |
+16,638
| New | +$125K |
|
1918
Ameresco
AMRC
$1.15B
| $122K | ﹤0.01% |
14,205
-4,586
| -24% | -$38.1K |
|
1919
Tempest Therapeutics
TPST
$14.8M
| $122K | ﹤0.01% |
+30
| New | +$126K |
|
|
CORI
1920
DELISTED
Corium International, Inc.
CORI
| $122K | ﹤0.01% |
+12,718
| New | +$136K |
|
|
BETR
1921
DELISTED
Amplify Snack Brands, Inc.
BETR
| $122K | ﹤0.01% |
+10,137
| New | +$72.9K |
|
|
MVF
1922
DELISTED
BlackRock MuniVest Fund
MVF
| $121K | ﹤0.01% |
+12,600
| New | +$122K |
|
|
PFNX
1923
DELISTED
Pfenex Inc.
PFNX
| $121K | ﹤0.01% |
45,673
-34,127
| -43% | -$94.5K |
|
|
MXWL
1924
DELISTED
Maxwell Technologies Inc
MXWL
| $120K | ﹤0.01% |
+20,788
| New | +$108K |
|
1925
Arcos Dorados Holdings
ARCO
$1.73B
| $118K | ﹤0.01% |
11,711
-3,332
| -22% | -$32.6K |
|
Similar funds
Squarepoint's Q4 2017 Portfolio in Review
As of Q4 2017, Squarepoint held 2,530 positions worth $5.74B, up 10% from $5.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Squarepoint deployed $368M of net new capital in Q4 2017, opening 949 new positions and adding to 622 existing holdings. Its largest new stake was Boston Scientific: 1,494,796 shares worth $37.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $50.9M trimmed.
- Squarepoint's largest Q4 2017 buy was Boston Scientific: 1,494,796 shares worth $37.1M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q4 2017, an estimated $203M increase.
- Squarepoint's biggest Q4 2017 reduction was Apple, cutting an estimated $50.9M.
- Squarepoint fully exited iShares MSCI Japan ETF in Q4 2017, selling an estimated $67M.
- Squarepoint's ten largest holdings make up 15% of its $5.74B portfolio in Q4 2017.
- Squarepoint opened 949 new positions and closed 486 in Q4 2017.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $5.74B.
Based on Squarepoint's 13F filing for Q4 2017, filed 14 Feb 2018.